Silo Pharma, Inc. current report, 20 May 2015

SEC Filing Summary: Point Capital, Inc. (8-K)

Business Context and Reporting Period

This Form 8-K Current Report, dated May 20, 2015, details the results of the annual meeting of stockholders for Point Capital, Inc. (Note: The input metadata references "Silo Pharma, Inc.", but the filing text explicitly identifies the registrant as Point Capital, Inc.). The meeting was held at the company's offices in Englewood, New Jersey.

Key Financial Metrics

The filing text does not provide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results.

Material Changes and Voting Results

As of the record date (April 27, 2015), there were 50,582,441 shares of common stock issued and outstanding. Proxies were received for 28,068,692 shares, representing 55.5% of the outstanding shares. There were no broker non-votes.

  • Proposal 1 (Election of Directors): All five nominees (Richard A. Brand, Eric Weisblum, Van E. Parker, Leonard Schiller, and Joel A. Stone) were elected unanimously with 28,068,692 votes for, 0 against, and 0 abstentions.
  • Proposal 2 (Executive Compensation Ratification): The non-binding proposal to approve executive compensation was approved. Votes: 27,887,025 For, 0 Against, 181,667 Abstained.
  • Proposal 3 (Frequency of Compensation Votes): Stockholders approved holding an advisory vote on executive compensation every three years. Votes: 25,666,682 for Three Years, 1,650,000 for Two Years, 502,010 for One Year, and 250,000 Abstained.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, financial guidance, outlook, risks, contingencies, or unusual items.

Investor Verification Checklist

  • Verify the correct registrant name is Point Capital, Inc., not Silo Pharma, Inc.
  • Confirm the 55.5% proxy participation rate relative to the 50,582,441 outstanding shares.
  • Note the unanimous election of the board of directors.
  • Observe the strong majority (approx. 94% of votes cast) favoring a three-year frequency for executive compensation advisory votes.